Artwork

Content provided by Bloomberg. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bloomberg or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

ICYMI: Elanco Shares Jump After 2Q Beat-and-Raise Results

12:16
 
Share
 

Manage episode 499016635 series 1504386
Content provided by Bloomberg. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bloomberg or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

On Thursday, Elanco Animal Health shares climbed by the most intraday since May, after the animal health firm boosted its adjusted profit and revenue guidance for the full year, following better-than-expected second-quarter results. Bloomberg Intelligence sees the launches of dog medications Credelio Quattro and Zenrelia bolstering Elanco's broader portfolio, with a big portion of new customers buying multiple products.

Jeff Simmons, Elanco's President and CEO, breaks down the firm's strategic framework and explains why he sees sustainable value creation continuing for years to come. Jeff speaks with Carol Massar and Norah Mulinda on Bloomberg Businessweek Daily.

See omnystudio.com/listener for privacy information.

  continue reading

4889 episodes

Artwork
iconShare
 
Manage episode 499016635 series 1504386
Content provided by Bloomberg. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bloomberg or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

On Thursday, Elanco Animal Health shares climbed by the most intraday since May, after the animal health firm boosted its adjusted profit and revenue guidance for the full year, following better-than-expected second-quarter results. Bloomberg Intelligence sees the launches of dog medications Credelio Quattro and Zenrelia bolstering Elanco's broader portfolio, with a big portion of new customers buying multiple products.

Jeff Simmons, Elanco's President and CEO, breaks down the firm's strategic framework and explains why he sees sustainable value creation continuing for years to come. Jeff speaks with Carol Massar and Norah Mulinda on Bloomberg Businessweek Daily.

See omnystudio.com/listener for privacy information.

  continue reading

4889 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play